Prognia
Drug Database
🇺🇸US · FDA ApprovedPrescriptionNDA217006-001

ABILIFY ASIMTUFII(ARIPIPRAZOLE)

Manufacturer: OTSUKA

FDA Approval: 27/04/2023

Route: INTRAMUSCULAR · SUSPENSION, EXTENDED RELEASE

Active Ingredients

ARIPIPRAZOLE 720MG/2.4ML (300MG/ML)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ABILIFY ASIMTUFII — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.